Herpes Zoster Ophthalmicus Clinical Trial 2017-055

[LCID Study Number: 2017-055]

Long-term Suppressive Valacyclovir Treatment for Herpes Zoster Ophthalmicus (ZEDS)

The purpose of this study is to find out whether one year of a low dose of the medicine valacyclovir reduces complications of shingles affecting the eye.

Disease/Condition: Herpes Zoster Ophthalmicus

Department: Ophthalmology

Location(s): Lahey Hospital & Medical Center (Burlington); Lahey Medical Center, Peabody

View NCT ID 03134196 on ClinicalTrials.gov
Protocol #: 2017-055
Principal Investigator(s): Sarkis H. Soukiasian
Study Coordinator(s): Sarkis H. Soukiasian
Trial Phase: Sponsor Initiated Study Phase 4